Life Line Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.60 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.00 Cr
as on 16-11-2024
- Company Age 38 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.70 Cr
as on 16-11-2024
- Revenue 63.94%
(FY 2023)
- Profit -66.88%
(FY 2023)
- Ebitda 69.82%
(FY 2023)
- Net Worth 0.39%
(FY 2023)
- Total Assets 22.94%
(FY 2023)
About Life Line Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.60 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹5.70 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Satish Agarwal, Santosh Agarwal, and Kapil Sharma serve as directors at the Company.
- CIN/LLPIN
U24239DL1986PLC025119
- Company No.
025119
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
14 Aug 1986
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Life Line Biotech Limited offer?
Life Line Biotech Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs, Pain Relief Drugs & Pharmaceuticals, Pain Killers, Pharmaceutical Medicine, Antacid Drugs, Digestive Drugs, Antacid Syrup, Anti Allergic Drug, Allergy Relief Tablets.
Who are the key members and board of directors at Life Line Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Agarwal  | Managing Director | 30-Sep-2003 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Santosh Agarwal | Whole-Time Director | 12-Nov-2008 | Current |
| Kapil Sharma | Director | 01-Sep-2016 | Current |
Financial Performance of Life Line Biotech.
Life Line Biotech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 63.94% increase. The company also saw a substantial fall in profitability, with a 66.88% decrease in profit. The company's net worth moved up by a moderate rise of 0.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Life Line Biotech?
In 2023, Life Line Biotech had a promoter holding of 87.00% and a public holding of 13.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 13 Oct 2007 | ₹4.50 Cr | Satisfied |
State Bank Of Bikaner & Jaipur Creation Date: 12 Jul 2005 | ₹1.05 Cr | Satisfied |
State Bank Of Bikaner & Jaipur Creation Date: 10 Feb 1995 | ₹0.75 M | Satisfied |
How Many Employees Work at Life Line Biotech?
Life Line Biotech has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Life Line Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Life Line Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
